"Pascagoula Hospital is a full-service, 435-bed hospital providing a large variety of inpatient and outpatient medical services on the Mississippi Gulf Coast. Our departments include: - Emergency Room - Cancer Care - Hospice Care - Inpatient and Outpatient Behavioral Health - Wound Care - Hospice of Light - Heart / Cardiac Care - Labor and Delivery - Pediatric Care - Rehabilitation Services"

During the past decade, Singing River Hospital conducted 34 clinical trials. In the 10-year time frame, 34 clinical trials started and 53 clinical trials were completed, i.e. on average, 155.9% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 28 clinical trials were completed. i.e. 560% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Singing River Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 52 trials, followed by "SWOG Cancer Research Network" with 16 trials sponsored, "Alliance for Clinical Trials in Oncology" with 7 trials sponsored, "GOG Foundation" with 4 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Singing River Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "Radiation Therapy Oncology Group" with 4 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Singing River Hospital" are "Recurrent Breast Carcinoma" (9 trials), "Breast Cancer" (7 trials), "Stage IV Breast Cancer AJCC v6 and v7" (7 trials), "Invasive Breast Carcinoma" (6 trials) and "HER2/Neu Negative" (5 trials). Many other conditions were trialed in "Singing River Hospital" in a lesser frequency.

Most popular intervention types in "Singing River Hospital" are "Drug" (75 trials), "Other" (68 trials), "Biological" (43 trials), "Radiation" (19 trials) and "Procedure" (16 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (49 trials), "Quality-of-Life Assessment" (23 trials), "Paclitaxel" (19 trials), "Bevacizumab" (14 trials) and "Carboplatin" (14 trials). Other intervention names were less common.

The vast majority of trials in "Singing River Hospital" are 67 trials for "All" genders, 26 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Singing River Hospital". undefined are not yet recruiting, 11 are recruiting, 43 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in Singing River Hospital, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Singing River Hospital, 4 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 57 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".

Singing River Hospital has several departments that took part in Clinical trials: "Regional Cancer Center at Singing River Hospital" - 64 trials, "The Neuroscience Center" - 2 trials